Neolixir Limited

Australie

Retour au propriétaire

1-7 de 7 pour Neolixir Limited Trier par
Recheche Texte
Affiner par
Type PI
        Marque 6
        Brevet 1
Juridiction
        International 3
        Canada 2
        États-Unis 2
Date
2025 2
2024 5
Classe IPC
A01N 37/02 - Acides carboxyliques saturés ou leurs thio-analoguesLeurs dérivés 1
A61K 31/19 - Acides carboxyliques, p. ex. acide valproïque 1
A61K 31/407 - Composés hétérocycliques ayant l'azote comme hétéro-atome d'un cycle, p. ex. guanéthidine ou rifamycines ayant des cycles à cinq chaînons avec un azote comme seul hétéro-atome d'un cycle, p. ex. sulpiride, succinimide, tolmétine, buflomédil condensés avec des systèmes hétérocycliques, p. ex. kétorolac, physostigmine 1
A61K 31/427 - Thiazoles non condensés et contenant d'autres hétérocycles 1
A61K 31/43 - Composés contenant des systèmes cycliques thia-4 aza-1 bicyclo [3.2.0] heptane, c.-à-d. composés contenant un système cyclique de formule , p. ex. pénicillines, pénèmes 1
Voir plus
Classe NICE
03 - Produits cosmétiques et préparations de toilette; préparations pour blanchir, nettoyer, polir et abraser. 6
05 - Produits pharmaceutiques, vétérinaires et hygièniques 6
31 - Produits agricoles; animaux vivants 6
01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture 2
Statut
En Instance 4
Enregistré / En vigueur 3

1.

LiXA

      
Numéro d'application 1845389
Statut Enregistrée
Date de dépôt 2024-10-25
Date d'enregistrement 2024-10-25
Propriétaire Neolixir Limited (Australie)
Classes de Nice  ?
  • 03 - Produits cosmétiques et préparations de toilette; préparations pour blanchir, nettoyer, polir et abraser.
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 31 - Produits agricoles; animaux vivants

Produits et services

Cosmetics. Pharmaceutical and veterinary products to maintain or enhance health or treat disease; antibiotics; pharmaceutical and veterinary products to prevent or treat infectious disease, autoimmune disease, inflammatory disease and other immune disorders; antibiotic adjuvants; Pharmaceutical and veterinary products, ingredients and preparations, namely, pharmaceutical products and preparations for the impairment and prevention of infection, including planktonic and microbial biofilm colonies, the reversal of microbial resistance, the potentiation of antimicrobial agents, endotoxicity protection, anti-inflammatory and immune system enhancement; pharmaceutical and nutraceutical products for enhancing microbiome health; extracellular matrix and extracellular polymeric substances including polysaccharides, monosaccharides, exopolysaccharides, and proteins being dietary supplements; antimicrobial biocide, antibiotic, bactericidal agents, bacteriostatic agents; antimicrobial resistance breakers; human and animal antimicrobial treatments; pharmaceutical and veterinary products and preparations to prevent or mitigate bacterial biofilms and infections; cleaning agents and disinfectants for medical purposes, cleaning agents and disinfectants for hygiene purposes, cleaning agents and disinfectants for veterinary purposes, antimicrobial cleaning agents and disinfectants. Animal feed.

2.

LIXA

      
Numéro d'application 1843907
Statut Enregistrée
Date de dépôt 2024-10-25
Date d'enregistrement 2024-10-25
Propriétaire Neolixir Limited (Australie)
Classes de Nice  ?
  • 03 - Produits cosmétiques et préparations de toilette; préparations pour blanchir, nettoyer, polir et abraser.
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 31 - Produits agricoles; animaux vivants

Produits et services

Cosmetics. Pharmaceutical and veterinary products to maintain or enhance health or treat disease; antibiotics; surfactants; pharmaceutical and veterinary products to prevent or treat infectious disease, autoimmune disease, inflammatory disease and other immune disorders; antibiotic adjuvants; Pharmaceutical and veterinary products, ingredients and preparations, namely, pharmaceutical products and preparations for the impairment and prevention of infection, including planktonic and microbial biofilm colonies, the reversal of microbial resistance, the potentiation of antimicrobial agents, endotoxicity protection, anti-inflammatory and immune system enhancement; pharmaceutical and nutraceutical products for enhancing microbiome health; extracellular matrix and extracellular polymeric substances including polysaccharides, monosaccharides, exopolysaccharides, and proteins for medical purposes; antimicrobial biocide, antibiotic, bactericidal agents, bacteriostatic agents; antibiotic resistance breakers; human and animal antimicrobial treatments; pharmaceutical and veterinary products and preparations to prevent or mitigate bacterial biofilms and infections; cleaning agents and disinfectants for medical purposes, cleaning agents and disinfectants for hygiene purposes, cleaning agents and disinfectants for veterinary purposes, antimicrobial cleaning agents and disinfectants. Animal feed.

3.

DYSREGULATION OF PLANKTONIC BACTERIAL METABOLISM

      
Numéro d'application AU2024050455
Numéro de publication 2024/229525
Statut Délivré - en vigueur
Date de dépôt 2024-05-09
Date de publication 2024-11-14
Propriétaire NEOLIXIR LIMITED (Australie)
Inventeur(s)
  • Barker, Andrew
  • Eijkenboom, Maud
  • Haese, Ethan Clark
  • Green, Kathryn
  • Abberton, Catherine

Abrégé

A composition comprising a 2-hydroxycarboxylic acid for dysregulating the metabolism of planktonic bacteria, and uses of the same.

Classes IPC  ?

  • A61K 31/19 - Acides carboxyliques, p. ex. acide valproïque
  • A01N 37/02 - Acides carboxyliques saturés ou leurs thio-analoguesLeurs dérivés
  • A61K 31/407 - Composés hétérocycliques ayant l'azote comme hétéro-atome d'un cycle, p. ex. guanéthidine ou rifamycines ayant des cycles à cinq chaînons avec un azote comme seul hétéro-atome d'un cycle, p. ex. sulpiride, succinimide, tolmétine, buflomédil condensés avec des systèmes hétérocycliques, p. ex. kétorolac, physostigmine
  • A61K 31/427 - Thiazoles non condensés et contenant d'autres hétérocycles
  • A61K 31/43 - Composés contenant des systèmes cycliques thia-4 aza-1 bicyclo [3.2.0] heptane, c.-à-d. composés contenant un système cyclique de formule , p. ex. pénicillines, pénèmes
  • A61K 31/496 - Pipérazines non condensées contenant d'autres hétérocycles, p. ex. rifampine, thiothixène ou sparfloxacine
  • A61K 31/53 - Composés hétérocycliques ayant l'azote comme hétéro-atome d'un cycle, p. ex. guanéthidine ou rifamycines ayant des cycles à six chaînons avec trois azote comme seuls hétéro-atomes d'un cycle, p. ex. chlorazanil, mélamine
  • A61K 31/65 - Tétracyclines
  • A61K 33/30 - ZincSes composés
  • A61K 33/34 - CuivreSes composés
  • A61K 38/12 - Peptides cycliques
  • A61K 38/14 - Peptides contenant des radicaux saccharideLeurs dérivés
  • A61L 2/18 - Procédés ou appareils de désinfection ou de stérilisation de matériaux ou d'objets autres que les denrées alimentaires ou les lentilles de contactAccessoires à cet effet utilisant des substances chimiques des substances liquides
  • A61L 101/36 - Acides carboxyliques ou leurs dérivés
  • A61P 31/04 - Agents antibactériens

4.

LIXA

      
Numéro d'application 238553500
Statut En instance
Date de dépôt 2024-10-25
Propriétaire Neolixir Limited (Australie)
Classes de Nice  ?
  • 03 - Produits cosmétiques et préparations de toilette; préparations pour blanchir, nettoyer, polir et abraser.
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 31 - Produits agricoles; animaux vivants

Produits et services

(1) Cosmetics. (2) Pharmaceutical and veterinary products to maintain or enhance health or treat disease; antibiotics; surfactants; pharmaceutical and veterinary products to prevent or treat infectious disease, autoimmune disease, inflammatory disease and other immune disorders; antibiotic adjuvants; Pharmaceutical and veterinary products, ingredients and preparations, namely, pharmaceutical products and preparations for the impairment and prevention of infection, including planktonic and microbial biofilm colonies, the reversal of microbial resistance, the potentiation of antimicrobial agents, endotoxicity protection, anti-inflammatory and immune system enhancement; pharmaceutical and nutraceutical products for enhancing microbiome health; extracellular matrix and extracellular polymeric substances including polysaccharides, monosaccharides, exopolysaccharides, and proteins for medical purposes; antimicrobial biocide, antibiotic, bactericidal agents, bacteriostatic agents; antibiotic resistance breakers; human and animal antimicrobial treatments; pharmaceutical and veterinary products and preparations to prevent or mitigate bacterial biofilms and infections; cleaning agents and disinfectants for medical purposes, cleaning agents and disinfectants for hygiene purposes, cleaning agents and disinfectants for veterinary purposes, antimicrobial cleaning agents and disinfectants. (3) Animal feed.

5.

LIXA

      
Numéro d'application 238691000
Statut En instance
Date de dépôt 2024-10-25
Propriétaire Neolixir Limited (Australie)
Classes de Nice  ?
  • 03 - Produits cosmétiques et préparations de toilette; préparations pour blanchir, nettoyer, polir et abraser.
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 31 - Produits agricoles; animaux vivants

Produits et services

(1) Cosmetics. (2) Pharmaceutical and veterinary products to maintain or enhance health or treat disease; antibiotics; pharmaceutical and veterinary products to prevent or treat infectious disease, autoimmune disease, inflammatory disease and other immune disorders; antibiotic adjuvants; Pharmaceutical and veterinary products, ingredients and preparations, namely, pharmaceutical products and preparations for the impairment and prevention of infection, including planktonic and microbial biofilm colonies, the reversal of microbial resistance, the potentiation of antimicrobial agents, endotoxicity protection, anti-inflammatory and immune system enhancement; pharmaceutical and nutraceutical products for enhancing microbiome health; extracellular matrix and extracellular polymeric substances including polysaccharides, monosaccharides, exopolysaccharides, and proteins being dietary supplements; antimicrobial biocide, antibiotic, bactericidal agents, bacteriostatic agents; antimicrobial resistance breakers; human and animal antimicrobial treatments; pharmaceutical and veterinary products and preparations to prevent or mitigate bacterial biofilms and infections; cleaning agents and disinfectants for medical purposes, cleaning agents and disinfectants for hygiene purposes, cleaning agents and disinfectants for veterinary purposes, antimicrobial cleaning agents and disinfectants. (3) Animal feed.

6.

LIXA

      
Numéro de série 98792313
Statut En instance
Date de dépôt 2024-10-09
Propriétaire Neolixir Limited (Australie)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 03 - Produits cosmétiques et préparations de toilette; préparations pour blanchir, nettoyer, polir et abraser.
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 31 - Produits agricoles; animaux vivants

Produits et services

Surfactants for use in connection with agricultural pesticides; extracellular matrix and extracellular polymeric substances namely polysaccharides, monosaccharides, exopolysaccharides, and proteins for use in the manufacture of agricultural pesticides, animal feed, veterinary products, cleaning agents and surface hygiene products Cosmetics; cleaning agents for medical purposes, cleaning agents for hygiene purposes, cleaning agents for veterinary purposes, antimicrobial cleaning agents Pharmaceutical products to maintain or enhance health or treat disease, namely infectious disease, autoimmune disease, inflammatory disease and other immune disorders ; veterinary products, namely pharmaceuticals, nutritional supplements, complementary health products, anti-infectives and anti-inflammatories; antibiotics; pharmaceutical products to prevent or treat infectious disease, autoimmune disease, inflammatory disease and other immune disorders; veterinary vaccines for livestock and companion animals for treating infectious disease, autoimmune disease, inflammatory disease and other immune disorders; antibiotic adjuvants; Pharmaceutical products, ingredients and preparations, namely, pharmaceutical preparations for the impairment and prevention of infection, namely planktonic and microbial biofilm colonies, the reversal of microbial resistance, the potentiation of antimicrobial agents, endotoxicity protection, anti-inflammatory and immune system enhancement; products which enhance the health of microbiomes, namely dietary supplements, gut health supportive treatments and products, functional foods; antimicrobial biocide, antibiotic, bactericidal agents, bacteriostatic agents for use in pharmaceuticals, medical materials such as wound dressings, sanitary preparations and animal health products; resistance breakers, namely, pharmaceuticals, medical materials, sanitary preparations and veterinary products; human and animal antimicrobial treatments, namely, antibiotics and pharmaceuticals to be administered alongside, or instead of, antibiotics; pharmaceutical preparations to prevent or mitigate bacterial biofilms and infections; disinfectants for medical purposes, disinfectants for hygiene purposes, disinfectants for veterinary purposes, antimicrobial disinfectants Animal feed

7.

LIXA

      
Numéro de série 98792320
Statut En instance
Date de dépôt 2024-10-09
Propriétaire Neolixir Limited (Australie)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 03 - Produits cosmétiques et préparations de toilette; préparations pour blanchir, nettoyer, polir et abraser.
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 31 - Produits agricoles; animaux vivants

Produits et services

Surfactants for use in connection with agricultural pesticides; extracellular matrix and extracellular polymeric substances namely polysaccharides, monosaccharides, exopolysaccharides, and proteins for use in the manufacture of agricultural pesticides, animal feed, veterinary products, cleaning agents and surface hygiene products Cosmetics; cleaning agents for medical purposes, cleaning agents for hygiene purposes, cleaning agents for veterinary purposes, antimicrobial cleaning agents Pharmaceutical products to maintain or enhance health or treat disease, namely infectious disease, autoimmune disease, inflammatory disease and other immune disorders ; veterinary products, namely pharmaceuticals, nutritional supplements, complementary health products, anti-infectives and anti-inflammatories; antibiotics; pharmaceutical products to prevent or treat infectious disease, autoimmune disease, inflammatory disease and other immune disorders; veterinary vaccines for livestock and companion animals for treating infectious disease, autoimmune disease, inflammatory disease and other immune disorders; antibiotic adjuvants; Pharmaceutical products, ingredients and preparations, namely, pharmaceutical preparations for the impairment and prevention of infection, namely planktonic and microbial biofilm colonies, the reversal of microbial resistance, the potentiation of antimicrobial agents, endotoxicity protection, anti-inflammatory and immune system enhancement; products which enhance the health of microbiomes, namely dietary supplements, gut health supportive treatments and products, functional foods; antimicrobial biocide, antibiotic, bactericidal agents, bacteriostatic agents for use in pharmaceuticals, medical materials such as wound dressings, sanitary preparations and animal health products; resistance breakers, namely, pharmaceuticals, medical materials, sanitary preparations and veterinary products; human and animal antimicrobial treatments, namely, antibiotics and pharmaceuticals to be administered alongside, or instead of, antibiotics; pharmaceutical preparations to prevent or mitigate bacterial biofilms and infections; disinfectants for medical purposes, disinfectants for hygiene purposes, disinfectants for veterinary purposes, antimicrobial disinfectants Animal feed